Misty Dawn Shields

@drshieldsmd

Translational Thoracic Oncologist #MDPhD, #SCLC, @TheShieldsLab, Indiana University, HHMI Med Into Grad Scholar/IASLC ILCF/ASCO CDA, founder @SCLCSMASHERS 🫁🤍

Indianapolis, IN

Joined September 2013

2KFollowing

2KFollowers

Pinned

Misty Dawn Shields@drshieldsmd · Apr 7, 2023

Always incredible to catch up with my lifelong mentor, hero, and friend, Dr. John Minna. @iaslungcancer #sclc23 #lcsm #mentorship #lungcancerresearch

drshieldsmd's tweet image. Always incredible to catch up with my lifelong mentor, hero, and friend, Dr. John Minna. @iaslungcancer #sclc23 #lcsm #mentorship #lungcancerresearch

20.0K

Pinned

Misty Dawn Shields@drshieldsmd · Jun 25

Y’all. I have the BEST lab. 🥼 “On Wednesdays, we wear pink.” Surprise, surprise. My lab surprised me today for my upcoming 40th (sigh) birthday with a party, fabulous cake 🎂, donuts 🍩 & wearing my favorite color! 💕 @TheShieldsLab at @IUCancerCenter is simply amazing!🤩

drshieldsmd's tweet image. Y’all. I have the BEST lab. 🥼

“On Wednesdays, we wear pink.”

Surprise, surprise.

My lab surprised me today for my upcoming 40th (sigh) birthday with a party, fabulous cake 🎂, donuts 🍩 &amp; wearing my favorite color! 💕

@TheShieldsLab at @IUCancerCenter is simply amazing!🤩

1.0K

Misty Dawn Shields@drshieldsmd · Jul 17

Thank you @UpstageLungCanc for sharing the exciting progress that brings HOPE in #SCLC! Listen to the podcast episode : 🔗 upstagelungcancer.org/podcasts/progr… @SclcSMASHERS @LUNGevity @dustywater @LiveLung1 @nursesteagall @HildyGrossman #LCSM

drshieldsmd's tweet image. Thank you @UpstageLungCanc for sharing the exciting progress that brings HOPE in #SCLC!

Listen to the podcast episode :

🔗 upstagelungcancer.org/podcasts/progr…

@SclcSMASHERS @LUNGevity @dustywater @LiveLung1 @nursesteagall @HildyGrossman #LCSM

511

Misty Dawn Shields@drshieldsmd · Jul 12

A friendly, funny, and fierce debate on the timing of IO for resectable NSCLC: ⭐️neoadj @gdurm vs ⭐️periop @RManiarMD vs ⭐️adjuvant @drshieldsmd Never a dull moment at a IU @ASCO Debate! 🏀 @IUCancerCenter #ASCO25 @Pacers @dallasmavs @nyknicks

drshieldsmd's tweet image. A friendly, funny, and fierce debate on the timing of IO for resectable NSCLC:

⭐️neoadj @gdurm vs
⭐️periop @RManiarMD vs
⭐️adjuvant @drshieldsmd

Never a dull moment at a IU @ASCO Debate! 🏀

@IUCancerCenter #ASCO25
@Pacers @dallasmavs @nyknicks

1.0K

Misty Dawn Shields Retweeted

Nabil Adra@nabiladra · Jul 12

Thoracic oncology debate at IU ASCO REVIEW 2025 is pretty intense with @drshieldsmd @gdurm and Dr. Rohan Maniar @IUCancerCenter @IUHemOnc @IUMedSchool

524

Misty Dawn Shields Retweeted

Nabil Adra@nabiladra · Jul 12

#ASCO president Dr. Robin Zon joins us for fireside chat at IU ASCO REVIEW to discuss ASCO presidency and her vision for the future of the field @IUCancerCenter @IUHemOnc @IUMedSchool #ASCO25

894

Misty Dawn Shields@drshieldsmd · Jul 12

Fantastic keynote fireside chat with 2024-2025 ASCO President Dr. Robin Zon (@ASCO) & @nabiladra at the @IUCancerCenter #ASCOReview25 on access, knowledge, and support to drive knowledge to action to build a better future for our patients and their families facing cancer.

drshieldsmd's tweet image. Fantastic keynote fireside chat with 2024-2025 ASCO President Dr. Robin Zon (@ASCO) &amp; @nabiladra at the @IUCancerCenter #ASCOReview25 on access, knowledge, and support to drive knowledge to action to build a better future for our patients and their families facing cancer.

1.0K

Misty Dawn Shields Retweeted

OncLive.com@OncLive · Jul 6

The sNDA seeking the approval of lurbinectedin and atezolizumab for the first-line treatment of select patients with ES-SCLC was granted priority review by the @US_FDA and was supported by data from the phase 3 IMforte trial. #FDA #LCSM Read more: hubs.li/Q03vpzLV0

2.0K

Misty Dawn Shields Retweeted

OncoDaily@oncodaily · Jul 4

ASCO - Applications for @ConquerCancerFd grants and awards are officially open @ASCO oncodaily.com/blog/asco-3233… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

486

Misty Dawn Shields@drshieldsmd · Jul 3

This is 40! Thank you to my sweet friends & family for ALL the amazing messages, gifts, and memories to make my day so special! Here’s to the next chapter! #imsoold

drshieldsmd's tweet image. This is 40! Thank you to my sweet friends &amp; family for ALL the amazing messages, gifts, and memories to make my day so special! Here’s to the next chapter! #imsoold

2.0K

Misty Dawn Shields@drshieldsmd · Jul 2

Thank you @ConquerCancerFd for highlighting my story & importance of funding research. Research drives meaningful change for our patients and their families, who face living with cancer every day. #researchcurescancer @IUCancerCenter @ASCO @SclcSMASHERS @TheShieldsLab

CConquer Cancer, the ASCO Foundation@ConquerCancerFd · Jul 2

Cancer doesn’t take a break, so neither can we. Help keep advancements in treatment and care moving forward for patients everywhere. Donate now to our #SummerFund and your gift will be matched up to $20K! brnw.ch/21wTRcq #ConquerCancer #CancerResearch

885

Misty Dawn Shields Retweeted

Rami Manochakian MD, FASCO Cancer Education@RManochakian · Jul 2

🔥🚨@OncoAlert Hot Off The Press @US_FDA approves: ✅ #Sunvozertinib For: 🔘Advanced non-small cell #LungCancer (#NSCLC) with: 🎯#EGFR #Exon20 insertion mutations, and disease progression on or after chemotherapy. ⭐️#ORR 46% and #DOR 11.1 months 👇🏻 fda.gov/drugs/resource…

4.0K

Misty Dawn Shields Retweeted

Narjust Florez, MD, FASCO@NarjustFlorezMD · Jul 1

Future areas of investigation for Young Lung Cancer? Follow the progress of our Young Lung Cancer Clinic and Research Program as we explore these issues and develop interventions to improve the experience of young patients with lung cancer.

1.0K

Misty Dawn Shields Retweeted

Hossein Borghaei, DO@HosseinBorghaei · Jun 29

Lung cancer took the life of another one of my patients today, only 48. A Veteran. Spirit unbreakable, great sense of humor. Despite advances, another reminder of the need for more progress as research funding gets thinner. Where do we go? How do we get there?

131

8.0K

Misty Dawn Shields Retweeted

Conquer Cancer, the ASCO Foundation@ConquerCancerFd · Jun 30

At #ASCO25, @ASCO brings together oncology pros to advance care. Conquer Cancer is proud to contribute to finding better treatments & care for people with cancer. Dive into our ASCO Annual Meeting Impact Report: brnw.ch/21wTNqL #CancerResearch

3.0K

Misty Dawn Shields Retweeted

Lung Cancer Europe@LungCancerEu · Jun 28

🚨 #Lungcancer survival has more than doubled. New real-world data from France shows 3-year survival for lung adenocarcinoma rose from 16.3% (2000) to 38.6% (2020) driven by earlier diagnosis & targeted treatment. This is what progress looks like. But it must reach everyone who…

130

277

41.0K

Misty Dawn Shields@drshieldsmd · Jun 27

Exciting to see how the field is moving forward for our patients with SCLC! #HawaiiLung25 @SclcSMASHERS @DAVAOnc

DDAVA Oncology@DAVAOnc · Jun 27

Dr. Millie Das (@DasMillie11) presented early-phase data on ABBV-706, a novel SEZ6-targeted ADC delivering a topo I payload. In relapsed/refractory SCLC, ORR reached 60.9%. Safety manageable; biomarker role still unclear. Combo trials with PD-1/platinum ongoing. #DAVALung

4.0K

Misty Dawn Shields Retweeted

LUNGevity Foundation@LUNGevity · Jun 26

You can't sit with us...unless you are Dr. Shields!!! What an awesome team you have!

160

Misty Dawn Shields Retweeted

Stephen V Liu, MD@StephenVLiu · Jun 25

International retrospective report on #EGFR NSCLC transformed to #SCLC now @ESMO_Open, led by Dr. @ChiaraCATANIA4. An area of significant unmet need - would like to see prospective studies here and I do think it is feasible. esmoopen.com/article/S2059-…

3.0K

Misty Dawn Shields Retweeted

Giannis Mountzios@g_mountzios · Jun 22

3 weeks after @ASCO25, let’s digest the data from the landmark DeLLphi-304 trial published in @NEJM that changed the >30 years SoC in recurrent #SCLC from immunobiology and clinical standpoints: 🧵 1/15 #some #LCSM @ASCO @IASLC @myESMO @etop_ibcsg @EORTC @SclcSMASHERS…

100

20.0K